Literature DB >> 27552836

Prefrontal Cortical GABAergic Dysfunction Contributes to Aberrant UP-State Duration in APP Knockout Mice.

Qingwei Huo1,2, Ming Chen2, Quansheng He2, Jiajia Zhang2, Bo Li2, Kai Jin2, Xi Chen2, Cheng Long2,3, Li Yang1,3,4,5.   

Abstract

Genetic and biochemical studies have focused on the role of amyloid β protein in the pathogenesis of Alzheimer's disease. In comparison, the physiological roles of its precursor protein, amyloid precursor protein (APP), in synaptic and network activity is less well studied. Using an APP knockout (APP-/-) mouse model, we show that the duration of UP state, which is a key feature of cortical synaptic integration occurring predominantly during slow-wave sleep, is significantly increased in the prefrontal cortex (PFC) in the absence of APP. This was accompanied by a specific reduction in the glutamine synthetase and tissue GABA content and sequential upregulation in the levels of GABABR expression. Pharmacological reinforcement of GABA signaling by application of either a GABA uptake inhibitor or an agonist of GABABR rescued the abnormality of UP-state duration and the former rescues altered GABABR expression as well. In addition to revealing an essential role of APP in the regulation of PFC network function, this study evidences the viability of GABA signaling pathway and its receptors, especially GABABRs, as a target for the treatment of aberrant neural network activity and thus information processing.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GABABR; UP states; amyloid precursor protein; glutamine synthetase; prefrontal cortex

Mesh:

Substances:

Year:  2017        PMID: 27552836     DOI: 10.1093/cercor/bhw218

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  6 in total

1.  Whole-cell Currents Induced by Puff Application of GABA in Brain Slices.

Authors:  Yangjian Feng; Binliang Tang; Ming Chen; Li Yang
Journal:  J Vis Exp       Date:  2017-10-12       Impact factor: 1.355

2.  New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation.

Authors:  Agata Mata; Vanessa Gil; Jeús Pérez-Clausell; Miguel Dasilva; Mari Carmen González-Calixto; Eduardo Soriano; José Manuel García-Verdugo; Maria V Sanchez-Vives; José Antonio Del Río
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

3.  Complex formation of APP with GABAB receptors links axonal trafficking to amyloidogenic processing.

Authors:  Margarita C Dinamarca; Adi Raveh; Andy Schneider; Thorsten Fritzius; Simon Früh; Pascal D Rem; Michal Stawarski; Txomin Lalanne; Rostislav Turecek; Myeongjeong Choo; Valérie Besseyrias; Wolfgang Bildl; Detlef Bentrop; Matthias Staufenbiel; Martin Gassmann; Bernd Fakler; Jochen Schwenk; Bernhard Bettler
Journal:  Nat Commun       Date:  2019-03-22       Impact factor: 14.919

4.  Jujuboside A prevents sleep loss-induced disturbance of hippocampal neuronal excitability and memory impairment in young APP/PS1 mice.

Authors:  Sidra Tabassum; Afzal Misrani; Bin-Liang Tang; Jian Chen; Li Yang; Cheng Long
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

5.  Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models.

Authors:  Ming Chen; Yunan Chen; Qingwei Huo; Lei Wang; Shuyi Tan; Afzal Misrani; Jinxiang Jiang; Jian Chen; Shiyuan Chen; Jiawei Zhang; Sidra Tabassum; Jichen Wang; Xi Chen; Cheng Long; Li Yang
Journal:  Mol Neurodegener       Date:  2021-03-04       Impact factor: 14.195

Review 6.  Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and Pharmacovigilance.

Authors:  Anna Papazoglou; Muhammad Imran Arshaad; Christina Henseler; Johanna Daubner; Karl Broich; Jürgen Hescheler; Dan Ehninger; Britta Haenisch; Marco Weiergräber
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.